Merck (MRK) Total Debt (2009 - 2025)

Merck has disclosed Total Debt across 17 years of filings, most recently posting $49.3 billion for FY2025.

• In Q1 2026, Total Debt rose 40.96% year-over-year to $49.1 billion; the TTM figure through Mar 2026 stood at $49.1 billion (up 40.96% YoY), while the FY2025 annual figure was $49.3 billion, up 32.95% from the prior year.
• Total Debt advanced to $49.3 billion in FY2025, from $37.1 billion in the prior year.
• Over the last five years, Total Debt for MRK reached as high as $49.3 billion in FY2025 and fell as low as $30.7 billion in FY2022.
• The 5-year median for Total Debt is $35.1 billion (2023), against an average of $37.1 billion.
• Annual changes were most pronounced in 2022 — Total Debt retreated 7.28% — and 2025, when it soared 32.95%.
• A 5-year view of Total Debt shows it stood at $33.1 billion in 2021, then dropped by 7.28% to $30.7 billion in 2022, then climbed by 14.22% to $35.1 billion in 2023, then increased by 5.87% to $37.1 billion in 2024, then soared by 32.95% to $49.3 billion in 2025.
• According to Business Quant data, Total Debt over the past three periods registered $49.3 billion, $37.1 billion, and $35.1 billion for FY2025, FY2024, and FY2023 respectively.